Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
alpha-Smooth Muscle Actin Antibody (SY02-64), Novus Biologicals™

Rabbit Monoclonal Antibody
Supplier: Novus Biologicals NBP267440
Description
alpha-Smooth Muscle Actin Monoclonal specifically detects alpha-Smooth Muscle Actin in Human, Mouse, Rat samples. It is validated for Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin.Specifications
| alpha-SmoothMuscleActin | |
| Monoclonal | |
| 1 mg/mL | |
| Western Blot 1:100-1:2000, Flow Cytometry 1:50-1:100, Immunohistochemistry 1:10 - 1:500, Immunocytochemistry/Immunofluorescence 1:10 - 1:500, Immunohistochemistry-Paraffin 1:50-1:200 | |
| AAT6, actin, alpha 2, smooth muscle, aorta, actin, aortic smooth muscle, ACTSA, ACTVS, alpha 2 actin, alpha SMA, alpha smooth muscle actin, alpha-actin-2, alpha-SMA, a-sma, Cell growth-inhibiting gene 46 protein, growth-inhibiting gene 46, sma, smooth muscle actin | |
| Rabbit | |
| 42 kDa | |
| 100 μL | |
| Primary | |
| Human, Mouse, Rat | |
| Purified |
| Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin) | |
| SY02-64 | |
| Unconjugated | |
| TBS (pH7.4), 0.05% BSA, 40% Glycerol with 0.05% Sodium Azide | |
| ACTA2 | |
| Synthetic peptide within N-terminal human alpha-Smooth Muscle Actin. (SwissProt: P62736 Human; SwissProt: P62737 Mouse; SwissProt: P62738 Rat) | |
| Protein A purified | |
| Angiogenesis, Cancer, Cardiovascular Biology, Cell Biology, Cellular Markers, Developmental Biology, Extracellular Matrix, Signal Transduction, Stem Cell Markers | |
| 59 | |
| Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles. | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction